MUSC - Hollings Cancer Center — Charleston, South Carolina

MUSC - Hollings Cancer Center is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

MUSC - Hollings Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia, Soft Tissue Sarcoma.

Sponsors: Xanthus Pharmaceuticals, Inc., Threshold Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MUSC - Hollings Cancer Center?

MUSC - Hollings Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MUSC - Hollings Cancer Center conducted?

MUSC - Hollings Cancer Center has 2 clinical trials on record. Their work covers Acute Myeloid Leukemia, Soft Tissue Sarcoma.

Is MUSC - Hollings Cancer Center accredited by Crixeo Health?

MUSC - Hollings Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MUSC - Hollings Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.